What is the projected market valuation for the US hospital acquired-infections market in 2035?

The projected market valuation for the US hospital acquired-infections market in 2035 is $10.5 Billion. Read More

What was the market valuation for the US hospital acquired-infections market in 2024?

The market valuation for the US hospital acquired-infections market in 2024 was $8.5 Billion. Read More

What is the expected CAGR for the US hospital acquired-infections market during the forecast period 2025 - 2035?

The expected CAGR for the US hospital acquired-infections market during the forecast period 2025 - 2035 is 1.94%. Read More

Which pathogen type segment had the highest valuation in 2024?

In 2024, the Bacteria segment had the highest valuation at $3.4 Billion. Read More

What are the projected valuations for Surgical Site Infections by 2035?

The projected valuation for Surgical Site Infections by 2035 is $3.15 Billion. Read More

Which hospital department segment is expected to grow the most by 2035?

The Intensive Care Unit segment is expected to grow the most, reaching $3.15 Billion by 2035. Read More

What is the valuation range for Infection Control Products from 2024 to 2035?

The valuation range for Infection Control Products is projected to increase from $2.5 Billion in 2024 to $3.0 Billion by 2035. Read More

Which key player is involved in the US hospital acquired-infections market?

Key players in the US hospital acquired-infections market include Johnson & Johnson and Becton Dickinson and Company. Read More

How does the market valuation for Bloodstream Infections change from 2024 to 2035?

The market valuation for Bloodstream Infections is expected to increase from $2.25 Billion in 2024 to $2.75 Billion by 2035. Read More

US Hospital Acquired infections Market

Q: What is the projected valuation for Catheter-Associated Urinary Tract Infections by 2035?

The projected valuation for Catheter-Associated Urinary Tract Infections by 2035 is $2.5 Billion. Read More

ID: MRFR/MED/11471-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Hospital Acquired infections Market Research Report: By Pathogen Type (Bacteria, Viruses, Fungi, Parasites), By Infection Type (Surgical Site Infections, Ventilator-Associated Pneumonia, Catheter-Associated Urinary Tract Infections, Bloodstream Infections), By Hospital Department (Intensive Care Unit, Surgery Department, Emergency Department, Pediatric Department) and By Treatment Type (Infection Control Products, Antibiotics, Disinfectants, Vaccines) - Growth & Industry Forecast 2025 To 2035

US Hospital Acquired infections Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Pathogen Type (USD Billion)
  1. 4.1.1 Bacteria
  2. 4.1.2 Viruses
  3. 4.1.3 Fungi
  4. 4.1.4 Parasites
2. 4.2 Food, Beverages & Nutrition, BY Infection Type (USD Billion)
  1. 4.2.1 Surgical Site Infections
  2. 4.2.2 Ventilator-Associated Pneumonia
  3. 4.2.3 Catheter-Associated Urinary Tract Infections
  4. 4.2.4 Bloodstream Infections
3. 4.3 Food, Beverages & Nutrition, BY Hospital Department (USD Billion)
  1. 4.3.1 Intensive Care Unit
  2. 4.3.2 Surgery Department
  3. 4.3.3 Emergency Department
  4. 4.3.4 Pediatric Department
4. 4.4 Food, Beverages & Nutrition, BY Treatment Type (USD Billion)
  1. 4.4.1 Infection Control Products
  2. 4.4.2 Antibiotics
  3. 4.4.3 Disinfectants
  4. 4.4.4 Vaccines
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson & Johnson (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Becton Dickinson and Company (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 3M Company (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Medtronic plc (IE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Stryker Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Abbott Laboratories (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cardinal Health, Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Thermo Fisher Scientific Inc. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY PATHOGEN TYPE
3. 6.3 US MARKET ANALYSIS BY INFECTION TYPE
4. 6.4 US MARKET ANALYSIS BY HOSPITAL DEPARTMENT
5. 6.5 US MARKET ANALYSIS BY TREATMENT TYPE
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY PATHOGEN TYPE, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY PATHOGEN TYPE, 2024 TO 2035 (USD Billion)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY INFECTION TYPE, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY INFECTION TYPE, 2024 TO 2035 (USD Billion)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY HOSPITAL DEPARTMENT, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY HOSPITAL DEPARTMENT, 2024 TO 2035 (USD Billion)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PATHOGEN TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY INFECTION TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY HOSPITAL DEPARTMENT, 2025-2035 (USD Billion)
  4. 7.2.4 BY TREATMENT TYPE, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Pathogen Type (USD Billion, 2025-2035)

Bacteria
Viruses
Fungi
Parasites

Food, Beverages & Nutrition By Infection Type (USD Billion, 2025-2035)

Surgical Site Infections
Ventilator-Associated Pneumonia
Catheter-Associated Urinary Tract Infections
Bloodstream Infections

Food, Beverages & Nutrition By Hospital Department (USD Billion, 2025-2035)

Intensive Care Unit
Surgery Department
Emergency Department
Pediatric Department

Food, Beverages & Nutrition By Treatment Type (USD Billion, 2025-2035)

Infection Control Products
Antibiotics
Disinfectants
Vaccines

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”